When asked by Fierce whether getting a phase-2-stage obesity drug to market within five years is too ambitious, Chakravarthy pointed to ways the company is continuing to build our core capabilities. This included on the manufacturing side, where the pharma recently broke ground on a $700 million plant in North Carolina that will be charged with, among other things, performing fill-finish duties for the company's injectable obesity drugs
For men or women with testosterone deficiency, combining testosterone therapy with GLP-1 treatment helps prevent muscle loss while losing weight
The differences between semaglutide and liraglutide are significant, so do not accept a substitution without understanding what you are getting
Intermittent fasting and caloric restriction may naturally synergize with MOTS-Cs effects
Though everyone benefits from balanced glutathione levels, men in particular need it when they face high stress, hormonal imbalances, and aging-related health decline